Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. ETF
  3. ICCM
ICCM logo

ICCM

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewTechnicalNews
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

ICCM News

IceCure Medical Completes Private Placement Financing

3d agoPRnewswire

IceCure Medical Completes Private Placement Financing

3d agoNewsfilter

IceCure Medical Receives FDA Authorization, Shares Surge 200%

3d agostocktwits

NeOnc Technologies Secures International Drug Authorization for NEO212

3d agoNewsfilter

IceCure Medical Sees Significant Growth Post FDA Approval

3d agoPRnewswire

IceCure Medical Sees Surge in ProSense® System Demand Following FDA Approval

3d agoNewsfilter

IceCure Medical Announces 1-for-30 Reverse Stock Split

Jun 02 2026seekingalpha

IceCure Medical Implements Reverse Split to Regain Nasdaq Compliance

Jun 02 2026PRnewswire

IceCure Medical Implements Reverse Split to Regain Nasdaq Compliance

Jun 02 2026Newsfilter

Breakthrough in Tumor Treatment with Cryoablation Technology

May 19 2026PRnewswire

IceCure Medical Receives 180-Day Nasdaq Compliance Extension

May 13 2026seekingalpha

IceCure Granted Extended Compliance Period by Nasdaq

May 13 2026PRnewswire

IceCure Granted Extended Compliance Period by Nasdaq

May 13 2026Newsfilter

IceCure Medical Reports Q1 2026 Financial Results

May 12 2026seekingalpha

IceCure Medical Reports Significant Growth in Q1 Performance

May 12 2026PRnewswire

IceCure Medical to Announce Q1 2026 Results and Host Conference Call

May 06 2026PRnewswire